Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors
Mehrdad Mehrazar, Mahdi Hassankalhori, Mahsa Toolabi, et al.
Molecular Diversity (2019) Vol. 24, Iss. 4, pp. 997-1013
Closed Access | Times Cited: 22

Showing 22 citing articles:

Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase
Rami J. Obaid, Nafeesa Naeem, Ehsan Ullah Mughal, et al.
RSC Advances (2022) Vol. 12, Iss. 31, pp. 19764-19855
Open Access | Times Cited: 85
An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities
Shah Alam Khan, Mohammad Jawaid Akhtar, Urvashee Gogoi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 47
Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential
Atamjit Singh, Karanvir Singh, Jashandeep Kaur, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 18, pp. 3291-3317
Closed Access | Times Cited: 16
The anti-Alzheimer potential of novel spiroindolin-1,2-diazepine derivatives as targeted cholinesterase inhibitors with modified substituents
Hormoz Pourtaher, Alireza Hasaninejad, Shahrokh Zare, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
A comprehensive review on triazole based conjugates as acetylcholinesterase inhibitors: Design strategies, synthesis, biological activity, structure activity relationships, molecular docking studies
Harmandeep Kaur Gulati, Nitish Kumar, Anchal Sharma, et al.
Journal of Molecular Structure (2023) Vol. 1284, pp. 135354-135354
Closed Access | Times Cited: 11
Immobilized nickel boride nanoparticles on magnetic functionalized multi-walled carbon nanotubes: a new nanocomposite for the efficient one-pot synthesis of 1,4-benzodiazepines
Farkhondeh Mohammad Aminzadeh, Behzad Zeynizadeh
Nanoscale Advances (2023) Vol. 5, Iss. 17, pp. 4499-4520
Open Access | Times Cited: 11
Design and synthesis of new 1,2,3-triazole-methoxyphenyl-1,3,4-oxadiazole derivatives: selective butyrylcholinesterase inhibitors against Alzheimer’s disease
Aida Iraji, Roshanak Hariri, Mohammad Hashem Hashempur, et al.
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access
Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors
Anita Nasli Esfahani, Aida Iraji, Amir Alamir, et al.
Molecular Diversity (2021) Vol. 26, Iss. 4, pp. 1995-2009
Open Access | Times Cited: 18
Synthesis, biological evaluation, molecular docking, and MD simulation of novel 2,4-disubstituted quinazoline derivatives as selective butyrylcholinesterase inhibitors and antioxidant agents
Sara Sadeghian, Raziyeh Razmi, Soghra Khabnadideh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease
Harish Kumar, Anju Goyal, Navneet Kumar, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 11, pp. 1931-1947
Closed Access | Times Cited: 9
Chemoinformatics Study of Benzodiazepine-1, 2, 3-triazole Derivatives Targeting Butyrylcholinesterase
Yassine El Allouche, Marwa Alaqarbeh, Abdellah El Aissouq, et al.
Journal of Fluorescence (2024)
Closed Access | Times Cited: 1
New benzamide derivatives and their nicotinamide/cinnamamide analogs as cholinesterase inhibitors
Mehmet Koca, Sinan Bilginer
Molecular Diversity (2021) Vol. 26, Iss. 2, pp. 1201-1212
Closed Access | Times Cited: 9
The synthesis and anti-inflammatory evaluation of 1,2,3-triazole linked isoflavone benzodiazepine hybrids
Gabriel Menghereş, Olumayokun A. Olajide, K. Hemming
ARKIVOC (2020) Vol. 2020, Iss. 7, pp. 306-321
Open Access | Times Cited: 8
Role of Computational Modeling in Drug Discovery for Alzheimer’s Disease
Mange Ram Yadav, Prashant R. Murumkar, Rahul Barot, et al.
Challenges and advances in computational chemistry and physics (2023), pp. 57-107
Closed Access | Times Cited: 3
Review of triazole scaffolds for treatment and diagnosis of Alzheimer's disease
Qi Li, Shulei Qi, Jinxin Liang, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110623-110623
Closed Access | Times Cited: 3
Chalcone derived benzoheterodiazepines for medicinal applications: A Two‐pot and one‐pot synthetic approach
Saba Farooq, Zainab Ngaini
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 10, pp. 1914-1928
Open Access | Times Cited: 7
Synthesis, Molecular Docking, and Biological Evaluation of Pyridin-3-yl-Pyrimidin-2-yl-Triazole Derivatives as Anti-cancer Agents
Loghman Firoozpour, Setareh Moghimi, Mohammad Hossein Fallah Barzegar, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 3, pp. 2062-2076
Closed Access | Times Cited: 2
1,2,3-Triazole Scaffold in Recent Medicinal Applications: Synthesis and Anticancer Potentials
Ratchanok Pingaew, Vanida Choomuenwai, Ronnakorn Leechaisit, et al.
Heterocycles (2022) Vol. 105, Iss. 1, pp. 147-147
Open Access | Times Cited: 4
Role of Target Fishing in Discovery of Novel Anti-Alzheimer’s Agents: In Silico Applications
Anjali Murmu, Balaji Wamanrao Matore, Purusottam Banjare, et al.
(2023), pp. 245-284
Closed Access | Times Cited: 1
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells
Michele Fiore, Michele Mosconi, Francesco Bonì, et al.
Molecules (2023) Vol. 28, Iss. 1, pp. 446-446
Open Access
1, 2, 3-triazole based conjugates-potential cholinesterase (AChE and BuChE) and BACE inhibitors for treatment of Alzheimer
R. D. Singh, Harpreet Kaur, Pankaj Gupta
AIP conference proceedings (2023) Vol. 2800, pp. 020313-020313
Closed Access
Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease
Harish Kumar, Anju Goyal, Navneet Kumar, et al.
Research Square (Research Square) (2022)
Open Access
Synthetic and Biological Importance of Benzodiazepines: A Systematic Review
Juliana G. de Morais, Clara S. C. Siqueira, Yasmine Batista Queiroz, et al.
Revista Virtual de Química (2022) Vol. 15, Iss. 3, pp. 480-4977
Open Access
Page 1

Scroll to top